76 Participants Needed

Cycle Therapy for Intestinal Obstruction

MR
Overseen ByMallory Royall, NP, DNP
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Wake Forest University Health Sciences
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Cycling has been a proven exercise for decades as a low impact option to strengthen the lower body and improve cardiovascular health. There is also evidence that cycling helps to stimulate the contraction of the muscles in the intestine. Other outcomes frequently examined when considering benefits of ambulation include decreased rates of venous thromboembolic events, pneumonia, and decreased hospital length of stays. Therefore, there is added value to consider alternate mobility modalities.

Research Team

MR

Mallory Royall, NP, DNP

Principal Investigator

Wake Forest University Health Sciences

Eligibility Criteria

This trial is for individuals with intestinal obstruction who are looking to improve their condition through exercise. Participants should be able to perform low-impact cycling and must not have any health issues that would limit their ability to safely engage in physical activity.

Inclusion Criteria

I have been diagnosed with a blockage in my small intestine.
I have been diagnosed with ileus.
Admission to NorthEast Acute Care Surgery
See 2 more

Exclusion Criteria

Pregnancy
Incarceration
I am under 18 years old.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in cycle therapy or ambulation as a mobility modality to encourage bowel function

4 weeks
Daily participation encouraged

Follow-up

Participants are monitored for safety and effectiveness after treatment, including rates of VTE and pneumonia

4 weeks

Treatment Details

Interventions

  • Cycle Therapy
Trial Overview The study is testing the effectiveness of cycle therapy as a treatment option for patients with intestinal obstruction. It aims to see if cycling can help stimulate muscle contractions in the intestines, potentially reducing hospital stays and preventing complications like blood clots and pneumonia.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Cycle therapyExperimental Treatment1 Intervention
The patient will either ambulate a short distance to recumbent bike which will be stored on the postsurgical 1 unit or be assisted out of bed to use floor cycle bike. After the patient demonstrates individual competency with either cycle modality, the patient may participate in this activity with nursing staff but will not require Physical Therapy (PT) presence at the time of use. This will allow the patient to participate multiple times a day if they choose.
Group II: ambulation as mobilization modalityActive Control1 Intervention
ambulation by surgical team

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security